0591 (0591) Fair Value & Analysis

Technology · Market cap HK$244M

0 0591 0591 · HK

PriceHK$0.2350

Fair ValueHK$0.3600

Upside+53.2%

Quality64/100

Evidence: High Range HK$0.2700 – HK$0.4500

Fair value as of: Jul 2, 2026

From 24 valuation models · updated today

Share price −6.0% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.2000 – HK$0.4950 · fair‑value band HK$0.2700 – HK$0.4500 · the HK$0.2350 price screens below the HK$0.3600 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0591 (0591) currently trades at HK$0.2350, while our model-based Fair Value estimate is HK$0.3600 — implying the stock looks roughly 53.2% undervalued today. We read business quality at 64/100 (solid quality), in the Technology sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, 0591 generated revenue of HK$163M at a net margin of 3.3%. Revenue declined 26.5% year over year. It earns a return on equity of 0.3%. The balance sheet holds a net cash position of HK$1.6B. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$163M

Revenue growth (YoY) -26.5%

Net margin 3.3%

Return on equity 0.3%

Free cash flow HK$37.6M FY2025

P/E ratio 23.5

More key figures

Operating margin 6.1%

EPS growth (YoY) -76.0%

Net cash HK$1.6B FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

0591 reported revenue of HK$209M in FY2025 versus HK$128M in FY2021, a compound +13.0%/yr. Reported net income was HK$18.8M in FY2025.

Revenue +13.0%/yr

FY21 HK$128M

FY22 HK$138M

FY23 HK$142M

FY24 HK$139M

FY25 HK$209M

Net income

FY21 −HK$25.9M

FY22 −HK$35.9M

FY23 −HK$22.7M

FY24 −HK$32.7M

FY25 HK$18.8M

Is 0591 fairly valued? → Check now

Similar stocks

6 more Scientific & Technical Instruments stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Keyence Corporation KYCCF	$457.38	$228.86	-50%
Keysight Technologies, Inc KEYS	$324.00	$92.23	-72%
Garmin Ltd GRMN	$236.41	$162.95	-31%
Chroma ATE Inc 2360	2,565 TWD	359.43 TWD	-86%
Teledyne Technologies Incorporated TDY	$602.27	$358.39	-40%
Hexagon AB HXGBF	$8.84	$5.23	-41%

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 0591 (0591) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.3600 versus a price of HK$0.2350 — about +53% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 0591?

Our model-based fair value for 0591 is HK$0.3600 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.2350.

What is the quality score of 0591?

0591 has a Quality Score of 64/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 0591 (0591)?

0591 reported trailing-twelve-month revenue of about HK$163M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 0591?

The net profit margin of 0591 is about 3.3%, meaning it keeps roughly 3.3% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.